Topic: European Union
Summary Box: Drugmakers post higher Q2 results, despite health reform, EU economic pressuresHEALTHY SIGNS: Three of the Top 20 drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — all post better second-quarter profit as their sales increase. ...
BRUSSELS (Reuters) - A European Union court backed an EU antitrust decision against Anglo-Swedish drugmaker AstraZeneca Thursday, lending weight to a regulatory crackdown on firms blocking cheaper drugs coming to market. Antitrust lawyers said the ruling set a firm legal precedent for ...
Individual EU nations will be free to ban genetically modified crops, even if they are deemed safe and approved, under rule changes being drawn up by Brussels to unblock the clearance process. EU Health Commissioner John Dalli, in charge of the emotive ...
LONDON (Reuters) - Drug companies have lost a legal battle against schemes promoted by Britain's state health service that encourage doctors to prescribe cheaper medicines. The Association of the British Pharmaceutical Industry (ABPI), representing dozens of pharmaceutical firms, argued that National Health ...
PARIS (Reuters) - Europe's food safety agency has used partial evidence to approve genetically modified crops, including a GM potato developed by BASF, and should overhaul its methods, a French environment minister said. France has previously invoked environmental risks to suspend cultivation ...
European Parliament President Jerzy Buzek said on Wednesday he was against genetically-modified foods but said they were an unavoidable part of the future. Asked by students in Sofia whether he was against GM foods, after the EU approved their cultivation, he said: ...
The European Commission on Tuesday approved the cultivation of genetically-modified potatoes, prompting an angry response from environmental campaign groups and two EU member governments. Austria said it was planning an immediate ban on the potatoes' cultivation, while Italy's agriculture minister slammed the ...
EU says it suspects Denmark's Lundbeck may have blocked launch of generic antidepressantsEuropean Union regulators said Thursday that they suspect Danish drug maker Lundbeck may have delayed the launch of a cheaper, generic version of its antidepressant drug in Europe. The European ...
PARIS (Reuters) - More research is needed into Monsanto's genetically modified maize MON 810, the only biotech crop commercially grown in Europe, to assess its environmental impact, a French advisory body said. The opinion given by biotech committee HCB, published on Tuesday, ...
European Union antitrust regulators said they made surprise raids on the offices of drug makers in several European nations Wednesday to seek evidence that they struck anticompetitive business deals or used a dominant market position to squeeze rivals. They did not name ...